Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP621453.RAYjjAIa9k621SS6L0Xq2EZlMC8RElQk5quOaE8lSO-fA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP621453.RAYjjAIa9k621SS6L0Xq2EZlMC8RElQk5quOaE8lSO-fA130_assertion type Assertion NP621453.RAYjjAIa9k621SS6L0Xq2EZlMC8RElQk5quOaE8lSO-fA130_head.
- NP621453.RAYjjAIa9k621SS6L0Xq2EZlMC8RElQk5quOaE8lSO-fA130_assertion description "[In analysis of individual SNPs, the GT/GG genotype of AKT1: rs2498804, CT/TT genotype of AKT1: rs2494732, and AG/AA genotype of PIK3CA: rs2699887 were associated with higher risk of brain metastasis at 24-month follow-up [respective HRs, 1.860, 95% confidence interval (CI) 1.199-2.885, P = 0.006; HR 1.902, 95% CI 1.259-2.875, P = 0.002; and HR 1.933, 95% CI 1.168-3.200, P = 0.010].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621453.RAYjjAIa9k621SS6L0Xq2EZlMC8RElQk5quOaE8lSO-fA130_provenance.
- NP621453.RAYjjAIa9k621SS6L0Xq2EZlMC8RElQk5quOaE8lSO-fA130_assertion evidence source_evidence_literature NP621453.RAYjjAIa9k621SS6L0Xq2EZlMC8RElQk5quOaE8lSO-fA130_provenance.
- NP621453.RAYjjAIa9k621SS6L0Xq2EZlMC8RElQk5quOaE8lSO-fA130_assertion SIO_000772 24077347 NP621453.RAYjjAIa9k621SS6L0Xq2EZlMC8RElQk5quOaE8lSO-fA130_provenance.
- NP621453.RAYjjAIa9k621SS6L0Xq2EZlMC8RElQk5quOaE8lSO-fA130_assertion wasDerivedFrom befree-20150227 NP621453.RAYjjAIa9k621SS6L0Xq2EZlMC8RElQk5quOaE8lSO-fA130_provenance.
- NP621453.RAYjjAIa9k621SS6L0Xq2EZlMC8RElQk5quOaE8lSO-fA130_assertion wasGeneratedBy ECO_0000203 NP621453.RAYjjAIa9k621SS6L0Xq2EZlMC8RElQk5quOaE8lSO-fA130_provenance.